MX2014000034A - Derivados de acidos carboxilicos con un anillo de oxazolo[4,5-c]piridina. - Google Patents

Derivados de acidos carboxilicos con un anillo de oxazolo[4,5-c]piridina.

Info

Publication number
MX2014000034A
MX2014000034A MX2014000034A MX2014000034A MX2014000034A MX 2014000034 A MX2014000034 A MX 2014000034A MX 2014000034 A MX2014000034 A MX 2014000034A MX 2014000034 A MX2014000034 A MX 2014000034A MX 2014000034 A MX2014000034 A MX 2014000034A
Authority
MX
Mexico
Prior art keywords
compound
formula
group
physiologically acceptable
alkyl
Prior art date
Application number
MX2014000034A
Other languages
English (en)
Spanish (es)
Inventor
Matthias Schäfer
Dieter Kadereit
Thomas Huebschle
Katrin Hiss
Stephanie Hachtel
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of MX2014000034A publication Critical patent/MX2014000034A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MX2014000034A 2011-07-07 2012-07-06 Derivados de acidos carboxilicos con un anillo de oxazolo[4,5-c]piridina. MX2014000034A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11305876 2011-07-07
EP12305524 2012-05-11
PCT/EP2012/063294 WO2013004824A1 (de) 2011-07-07 2012-07-06 Carbonsäurederivate mit einem oxazolo[4,5-c]pyridinring

Publications (1)

Publication Number Publication Date
MX2014000034A true MX2014000034A (es) 2014-02-17

Family

ID=46466550

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014000034A MX2014000034A (es) 2011-07-07 2012-07-06 Derivados de acidos carboxilicos con un anillo de oxazolo[4,5-c]piridina.

Country Status (12)

Country Link
US (1) US8907093B2 (ja)
EP (1) EP2729472B1 (ja)
JP (1) JP5984924B2 (ja)
KR (1) KR20140061383A (ja)
CN (1) CN103781791B (ja)
AU (1) AU2012280204B2 (ja)
BR (1) BR112014000085A2 (ja)
CA (1) CA2841214A1 (ja)
MX (1) MX2014000034A (ja)
MY (1) MY164138A (ja)
RU (1) RU2609004C2 (ja)
WO (1) WO2013004824A1 (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8735402B2 (en) * 2011-07-07 2014-05-27 Sanofi Cycloalkyloxycarboxylic acid derivatives
US9321787B2 (en) 2011-07-07 2016-04-26 Sanofi Carboxylic acid derivatives having an oxazolo[5,4-d]pyrimidine ring
US8580816B2 (en) * 2011-07-07 2013-11-12 Sanofi Carboxylic acid derivatives having an oxazolo[5,4-b]pyridine ring
EP2990055B1 (en) 2013-04-26 2019-06-05 Kyoto University Composition comprising a sphingosine-1-phosphate receptor 1 agonist for inhibiting formation and/or enlargement of cerebral aneurysm or for shrinking it

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO143535C (no) * 1972-06-14 1981-03-04 Merck & Co Inc Analogifremgangsmaate ved fremstilling av terapeutisk aktive oxazolopyridiner
PT1390371E (pt) * 2001-05-14 2006-07-31 Novartis Ag Oxazolo- e furopirimidinas e sua utilizacao em medicamentos contra tumores
CL2004001120A1 (es) * 2003-05-19 2005-04-15 Irm Llc Compuestos derivados de amina sustituidas con heterociclos, inmunosupresores; composicion farmaceutica; y uso para tratar enfermedades mediadas por interacciones de linfocito, tales como enfermedades autoinmunes, inflamatorias, infecciosas, cancer.
CN101277965A (zh) * 2005-08-04 2008-10-01 西特里斯药业公司 作为SIRTUIN调节化合物的咪唑并[2,1-b]噻唑衍生物
AU2006317689B2 (en) * 2005-11-23 2013-07-25 Epix Delaware, Inc. S1P receptor modulating compounds and use thereof
EP1900729A1 (en) * 2006-09-15 2008-03-19 Novartis AG Benzoxazoles and oxazolopyridines being useful as Janus kinases inhibitors
ES2554772T3 (es) 2008-05-30 2015-12-23 Merck Sharp & Dohme Corp. Azabenzoxazoles sustituidos novedosos
TW201000099A (en) 2008-06-20 2010-01-01 Amgen Inc S1P1 receptor agonists and use thereof
JP5449346B2 (ja) 2008-07-15 2014-03-19 サノフイ Ｅｄｇ−１受容体アゴニストとしてのオキサゾロピリミジン類
US8580816B2 (en) * 2011-07-07 2013-11-12 Sanofi Carboxylic acid derivatives having an oxazolo[5,4-b]pyridine ring

Also Published As

Publication number Publication date
US8907093B2 (en) 2014-12-09
EP2729472B1 (de) 2016-08-24
EP2729472A1 (de) 2014-05-14
RU2609004C2 (ru) 2017-01-30
MY164138A (en) 2017-11-30
JP2014518246A (ja) 2014-07-28
AU2012280204B2 (en) 2016-09-22
CN103781791A (zh) 2014-05-07
AU2012280204A1 (en) 2014-01-23
WO2013004824A1 (de) 2013-01-10
US20130023558A1 (en) 2013-01-24
CN103781791B (zh) 2016-04-06
KR20140061383A (ko) 2014-05-21
RU2014104244A (ru) 2015-08-20
CA2841214A1 (en) 2013-01-10
JP5984924B2 (ja) 2016-09-06
BR112014000085A2 (pt) 2017-01-10

Similar Documents

Publication Publication Date Title
AU2011206613B2 (en) Carboxylic acid derivatives having a 2,5,7-substituted oxazolopyrimidine ring
AU2012280204B2 (en) Carboxylic acid derivatives having an oxazolo[4,5-C]pyridine ring
AU2011206614B8 (en) Heterocyclic carboxylic acid derivatives having A 2,5,7-substituted oxazolopyrimidine ring
AU2011206617B2 (en) 2,5-substituted oxazolopyrimidine derivatives
AU2012280207B2 (en) Carboxylic acid derivatives having an oxazolo[5,4-D]pyrimidine ring
AU2012280206B2 (en) Carboxylic acid derivatives having an oxazolo[5,4-B]pyridine ring
JP5913586B2 (ja) オキサゾロ［４，５−ｃ］ピリジン環を有するカルボン酸誘導体